Compare ARK Genomic Revolution ETF (ARKG) vs Diamondback Energy Inc (FANG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Diamondback Energy Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.09, while Diamondback Energy Inc trades at $188.67 (market cap $51.59B). The key difference: Diamondback Energy Inc pays a 2.4% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Diamondback Energy Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | FANG | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $213.69 |
52-Week Low | $23.09 | $134.53 |
Market Cap | — | $51.59B |
Enterprise Value | — | $65.31B |
Dividend Yield | — | 2.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Diamondback Energy (FANG) trades at $183.39, up 0.76% on the day, with a bearish technical signal and neutral oscillators. The company reported mixed Q1 2026 earnings, beating estimates with EPS of $4.23 versus $3.74 expected, but missed Q4 2025. Revenue grew to $14.93B in 2025, though net income margin compressed to 1.88%. Analyst consensus remains strongly bullish with a $234.50 price target, while recent news highlights sector volatility amid oil price fluctuations and upcoming Q2 2026 earnings on August 3, 2026.
FANG presents a growth opportunity with strong analyst support and expanding revenue, but faces risks from declining profit margins, high P/E of 187.13, and oil market sensitivity. The stock's 22% upside to consensus target is tempered by execution risks and macroeconomic headwinds, requiring careful monitoring of Q2 earnings and oil price trends for directional clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →
